PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $86,000 | -77.5% | 26,918 | -79.5% | 0.00% | – |
| Q2 2020 | $382,000 | -49.0% | 131,086 | -50.7% | 0.00% | – |
| Q1 2020 | $749,000 | -21.3% | 265,843 | -9.3% | 0.00% | – |
| Q4 2019 | $952,000 | -72.8% | 293,235 | -81.9% | 0.00% | -100.0% |
| Q3 2019 | $3,500,000 | +164.2% | 1,620,501 | +284.1% | 0.00% | – |
| Q2 2019 | $1,325,000 | -72.1% | 421,845 | -66.9% | 0.00% | -100.0% |
| Q1 2019 | $4,746,000 | +170.6% | 1,275,955 | +111.0% | 0.00% | 0.0% |
| Q4 2018 | $1,754,000 | -16.3% | 604,753 | -24.1% | 0.00% | 0.0% |
| Q3 2018 | $2,095,000 | +3.2% | 796,532 | -8.2% | 0.00% | 0.0% |
| Q2 2018 | $2,031,000 | -52.2% | 867,693 | -40.0% | 0.00% | 0.0% |
| Q1 2018 | $4,252,000 | -59.0% | 1,446,604 | -61.8% | 0.00% | -66.7% |
| Q4 2017 | $10,378,000 | +11.3% | 3,787,928 | +37.7% | 0.00% | 0.0% |
| Q3 2017 | $9,328,000 | +803.9% | 2,751,835 | +558.2% | 0.00% | – |
| Q2 2017 | $1,032,000 | -87.5% | 418,103 | -88.5% | 0.00% | -100.0% |
| Q1 2017 | $8,274,000 | -29.0% | 3,644,132 | -33.7% | 0.00% | -50.0% |
| Q4 2016 | $11,658,000 | +174.1% | 5,498,136 | +333.0% | 0.00% | +100.0% |
| Q3 2016 | $4,253,000 | +69.9% | 1,269,781 | +59.2% | 0.00% | 0.0% |
| Q2 2016 | $2,503,000 | -52.8% | 797,424 | -49.9% | 0.00% | -50.0% |
| Q1 2016 | $5,298,000 | -31.4% | 1,590,691 | -27.1% | 0.00% | -33.3% |
| Q4 2015 | $7,725,000 | +177.3% | 2,182,005 | +293.9% | 0.00% | +200.0% |
| Q3 2015 | $2,786,000 | -34.2% | 553,889 | -15.9% | 0.00% | 0.0% |
| Q2 2015 | $4,235,000 | -61.7% | 658,652 | -58.1% | 0.00% | -75.0% |
| Q1 2015 | $11,055,000 | -10.8% | 1,571,462 | -2.3% | 0.00% | -20.0% |
| Q4 2014 | $12,396,000 | -31.2% | 1,607,840 | -33.4% | 0.01% | -28.6% |
| Q3 2014 | $18,023,000 | +48.8% | 2,412,673 | +92.8% | 0.01% | +40.0% |
| Q2 2014 | $12,110,000 | +48.8% | 1,251,202 | +27.8% | 0.01% | +66.7% |
| Q1 2014 | $8,136,000 | -43.2% | 979,062 | -42.3% | 0.00% | -50.0% |
| Q4 2013 | $14,333,000 | +60.4% | 1,698,232 | +51.4% | 0.01% | +50.0% |
| Q3 2013 | $8,938,000 | +2.7% | 1,121,429 | -0.5% | 0.00% | 0.0% |
| Q2 2013 | $8,705,000 | – | 1,127,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |